Investors in Health

UCB Ventures is a €150 million strategic corporate venture fund. UCB is a global biopharmaceutical company focused on neurology and immunology disorders, driven by innovative science to enhance patient lives worldwide. We work closely and forge strong connections with patients, caregivers, health care professionals and other stakeholders who know the challenges of these diseases and where the unmet needs are found all too well.

HSBC Provides banking and financial services organizations. It serve approximately 40 million customers through our global businesses: Wealth and Personal Banking, Commercial Banking, and Global Banking & Markets. Our network covers 64 countries and territories in Europe, Asia, the Middle East and Africa, North America and Latin America.

Founded in August 2015, Hikma Ventures operates as the corporate venture capital arm of Hikma Pharmaceuticals. Our primary focus is to identify and invest in emerging companies in the digital health space, globally, that could enhance Hikma’s value proposition, reputation and market intelligence. We will also consider investments in other healthcare related areas of current or future strategic interest to Hikma, including drug delivery technologies that have the potential to enhance Hikma's value chain and pipeline.

A subsidiary of Swiss health insurance Helsana, our goal is to improve efficiency and the provision of care in the Swiss healthcare system. Helsana Health Invest invests in start-ups dedicated to health. It’s our way of contributing to a higher quality of healthcare and increasing efficiency in the healthcare system. Helsana: Switzerland's top health insurer offering comprehensive health and accident insurance services to individuals and companies, with over 1.9 million policyholders and a strong focus on prevention and occupational health management.

Evonik Venture Capital is the corporate venture arm of Evonik Industries AG, one of the providers of specialty chemicals. Evonik Venture Capital invests in young companies with innovative technology and high growth potential with solutions to problems within the areas of focus of resource efficiency, specialty additives, health & care, nutrition. Leading in specialty chemicals and beyond to make the world a better place. We are an international group with a workforce of over 32,000 people spread across more than one hundred locations.

Kinston Capital is an investment firm focused on APAC territories, with a presence in London, Geneva, and Seoul.Kinston Capital Ltd. is a global investment firm specializing in APAC territories, offering strategic advisory services and expertise in wealth management, compliance, and alternative investments for client growth.

Roquette Ventures invests in food, nutrition, and health entrepreneurs.Roquette is a family-owned global leader in plant-based ingredients, specializing in plant proteins and pharmaceutical excipients. With a focus on innovation and sustainability, Roquette develops natural solutions for food, nutrition, and health market.

Birds of a feather flock together? Not our style! We promote healthcare startups who believe in their vision and want to be a success at it. DocCheck Guano is a hatchery for precocial birds aiming to land in the market. We provide the ideal fertiliser for startups: capital, know-how, market access and network. Oh, and our focus is on seed funding.

Healthware Ventures is the corporate venture capital arm of Healthware Group.Healthware Ventures, formerly known as Esense Ventures, is a venture incubator specializing in the digital transformation of healthcare. We support startups with leadership potential by providing funding, agency services, and access

Addington, founded by top-level executive and serial entrepreneur Ad Nederlof, invests in startups and scaleups that require funding and hands-on experience to accommodate growth. Addington aims at acquiring minority equity positions in startups and scaleups that require funding and targeted support in order to take the next step in their development. Addington’s expertise is highly varied, but best serves companies that offer scalable solutions on a recurring revenue model. Eligible companies ideally have a turnover of € 2 million and the potential to achieve continuous annual growth of 25 percent or higher. Besides funding, Addington provides guidance and advice based on many years of entrepreneurship and experience in international business. Addington holds standards and values that correspond with a genuine family business. To take full advantage of our expertise, a cultural match is a prerequisite. Internationally acclaimed business executive and entrepreneur Ad Nederlof is the classic example of “newspaper boy to captain of industry”. With little or no formal schooling to boast, he now holds a career of well over 50 years in the IT-industry – and the end is by no means in sight. Started off as a sales representative he worked his way up to executive positions until he could grow no further. Curious to put his vision of delivering excellent customer service to the test – and his own money where his mouth was – in 2005, at the age of 57, he started VANAD (‘owned by Ad’). Spurred by his enthusiasm, VANAD has grown from 20 to 2,000 employees since then. Throughout the years Ad added several rapidly growing companies to the portfolio. One of them, Enovation, he sold in 2018 for over € 100 million. Money he is now putting to work through Addington. With his vision, drive and insights as an invaluable bonus for entrepreneurs who – just like Ad – like to push further.

Brightlands Life Sciences Ventures is a corporate venture arm of Brightlands Maastricht Health Campus.Brightlands is a network of four innovation campuses in Limburg, where researchers, entrepreneurs, and students collaborate to develop sustainable solutions in materials, health, and nutrition.

Esperante is a private limited Netherlands-based seed investments company incorporated in January 2004. Esperante brings significant expertise and a human healthcare industry contacts network gained through up to three decades of cross-functional management experience. This background provides investment portfolio companies with extended management resources, particularly in Business Development, as a complement to Esperante's financial contribution.